Associate Director, Advanced Analytics & AI Enablement
Revolution Medicines - Redwood City, California, United States
Posted Oct 26, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $186K-$233K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $111,944 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +13.7% - Much faster than average
87% above the BLS role benchmark for data and ml aggregate.
Matched to SOC 15-1252 - Data and ML aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Associate Director, Advanced Analytics & AI Enablement Redwood City, California, United States Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: Reporting to the Director, US Commercial Analytics, the Associate Director, Advanced Analytics & AI Enablement will own the specialist predictive and causal methods that improve targeting, promotional investment, and commercial decisions across Revolution Medicines' portfolio. As RevMed prepares for overlapping launches across multiple cancers, many priority HCPs are likely to be relevant to more than one brand, making it essential to determine which customers to prioritize, for which brands, and at what level of investment. This is a build role. You will establish patient identification and predictive targeting capability, stand up promotional-effectiveness and marketing-mix measurement, and define the model governance standards that keep methodological ownership inside RevMed. You will also partner on AI-enabled analytics products that move the organization toward trusted, self-service access to commercial data. This
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Associate Director, Omnichannel Analytics
Revolution Medicines - Redwood City, California, United States
Associate Director, Omnichannel Analytics
BridgeBio Pharma, Inc. - Palo Alto - 3160 Porter; San Francisco - 1800 Owens
Director, Biostatistics
Tango Therapeutics Inc - Boston, MA
Director of Bioinformatics and Machine Learning
Natera, Inc. - San Carlos, CA